“I would say that we would see an acceleration (in drug sales), especially in the second half of the year, with the introduction of new products, with the acceleration also of the penetration of the oncology line in the non-U.S. markets,”
“Our pharmaceuticals division gained additional market share, with all major products contributing to this strong performance, particularly our new cancer medicines,”
“It became a drug which was difficult to commercialize, ... We sat there with a drug in which we had invested a significant amount of development and where we had sales that were less than exciting.”
“This unprecedented transaction significantly strengthens our position, as it enables Roche to become a leader in the second-largest pharmaceuticals market worldwide and adds global access to Chugai's solid research and development pipeline,”
